Limits...
Erratum to: No clinically significant drug interactions between lenalidomide and P-glycoprotein substrates and inhibitors: results from controlled phase I studies in healthy volunteers

View Article: PubMed Central

No MeSH data available.


Mean (±standard deviation) renal excretion-time profile of lenalidomide alone and in the presence of (a) quinidine or (b) temsirolimus in healthy subjects
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC4643567&req=5

Fig3: Mean (±standard deviation) renal excretion-time profile of lenalidomide alone and in the presence of (a) quinidine or (b) temsirolimus in healthy subjects

Mentions: The correct Fig. 3 is given below.Fig. 3


Erratum to: No clinically significant drug interactions between lenalidomide and P-glycoprotein substrates and inhibitors: results from controlled phase I studies in healthy volunteers
Mean (±standard deviation) renal excretion-time profile of lenalidomide alone and in the presence of (a) quinidine or (b) temsirolimus in healthy subjects
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC4643567&req=5

Fig3: Mean (±standard deviation) renal excretion-time profile of lenalidomide alone and in the presence of (a) quinidine or (b) temsirolimus in healthy subjects
Mentions: The correct Fig. 3 is given below.Fig. 3

View Article: PubMed Central

No MeSH data available.